Enzymotec (ENZY) Tops Q2 EPS by 5c, Updates FY Guidance

Enzymotec (NASDAQ: ENZY) reported Q2 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.39 million.

Enzymotec sees FY2015 EPS of $0.28-$0.36, versus the consensus of $0.28. Enzymotec sees FY2015 revenue of $53-59 million, versus the consensus of $53.38 million.

For earnings history and earnings-related data on Enzymotec (ENZY) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• Dollar General (DG) Tops Q2 EPS by 48c, Beats on Revenue; Offers FY27 EPS Guidance